STOCK TITAN

[Form 4] GRAIL, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

GRAIL, Inc. (GRAL) reported insider stock sales by President Joshua Ofman on a Form 4. On 10/15/2025, he sold 8,865 shares of common stock at an average price of $76.0276. On 10/16/2025, he sold 6,114 shares at an average price of $82.01.

Following these transactions, Ofman beneficially owns 381,818 shares directly. The filing notes the sales were made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025.

GRAIL, Inc. (GRAL) ha riportato vendite di azioni da parte di insider da parte del presidente Joshua Ofman su un modulo 4. Il 15/10/2025 ha venduto 8.865 azioni ordinarie a un prezzo medio di 76,0276 dollari. Il 16/10/2025 ha venduto 6.114 azioni a un prezzo medio di 82,01 dollari.

Dopo queste operazioni, Ofman detiene direttamente 381.818 azioni in modo beneficiario. Il documento segnala che le vendite sono avvenute ai sensi di un piano di trading Rule 10b5-1 adottato il 13 marzo 2025.

GRAIL, Inc. (GRAL) informó ventas de acciones por parte de un insider, el presidente Joshua Ofman, en un Formulario 4. El 15/10/2025 vendió 8,865 acciones comunes a un precio medio de 76,0276 USD. El 16/10/2025 vendió 6,114 acciones a un precio medio de 82,01 USD.

Tras estas transacciones, Ofman posee directamente 381,818 acciones. El documento señala que las ventas se realizaron conforme a un plan de negociación Rule 10b5-1 adoptado el 13 de marzo de 2025.

GRAIL, Inc. (GRAL)가 사장 Joshua Ofman에 의한 내부자 주식 매도를 Form 4에 보고했습니다. 2025년 10월 15일, 그는 보통주 8,865주를 평균가 76.0276달러에 매도했습니다. 2025년 10월 16일에는 6,114주를 평균가 82.01달러에 매도했습니다.

이 거래 후, Ofman은 직접 381,818주를 유익하게 보유합니다. 신고서에는 매도가 2025년 3월 13일에 채택된 Rule 10b5-1 거래 계획에 따라 이루어졌다고 명시되어 있습니다.

GRAIL, Inc. (GRAL) a signalé des ventes d’actions par un initié, le président Joshua Ofman, sur un formulaire 4. Le 15/10/2025, il a vendu 8 865 actions ordinaires à un prix moyen de 76,0276 dollars. Le 16/10/2025, il a vendu 6 114 actions à un prix moyen de 82,01 dollars.

Suite à ces transactions, Ofman détient directement 381 818 actions. Le dossier indique que les ventes ont été effectuées en vertu d’un plan de négociation Rule 10b5-1 adopté le 13 mars 2025.

GRAIL, Inc. (GRAL) meldete Insider-Verkäufe von Präsident Joshua Ofman in einem Formular 4. Am 15.10.2025 verkaufte er 8.865 Stammaktien zu einem durchschnittlichen Preis von 76,0276 USD. Am 16.10.2025 verkaufte er 6.114 Aktien zu einem durchschnittlichen Preis von 82,01 USD.

Nach diesen Transaktionen hält Ofman direkt 381.818 Aktien. Die Einreichung vermerkt, dass die Verkäufe gemäß einem am 13. März 2025 angenommenen Rule 10b5-1-Handelsplan erfolgt sind.

GRAIL, Inc. (GRAL) أعلنت عن مبيعات داخلية للأسهم من قبل الرئيس Joshua Ofman في نموذج 4. في 15/10/2025 باع 8,865 سهماً من الأسهم العادية بسعر متوسط قدره 76.0276 دولار. في 16/10/2025 باع 6,114 سهماً بسعر متوسط 82.01 دولار.

بعد هذه المعاملات، يمتلك أوفمان بشكل فاعل 381,818 سهماً بشكل مباشر. أشارت الوثيقة إلى أن عمليات البيع تمت وفقاً لخطة تداول Rule 10b5-1 المعتمدة في 13 مارس 2025.

GRAIL, Inc. (GRAL) 报告,由董事长 Joshua Ofman 进行的内部人士股票出售,填写在表格4上。2025年10月15日,他以平均价76.0276美元出售了8,865股普通股。2025年10月16日,他以平均价82.01美元出售了6,114股。

在这些交易之后,Ofman 直接持有381,818股股份。备案表指出,这些出售是根据2025年3月13日采纳的Rule 10b5-1交易计划进行的。

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

GRAIL, Inc. (GRAL) ha riportato vendite di azioni da parte di insider da parte del presidente Joshua Ofman su un modulo 4. Il 15/10/2025 ha venduto 8.865 azioni ordinarie a un prezzo medio di 76,0276 dollari. Il 16/10/2025 ha venduto 6.114 azioni a un prezzo medio di 82,01 dollari.

Dopo queste operazioni, Ofman detiene direttamente 381.818 azioni in modo beneficiario. Il documento segnala che le vendite sono avvenute ai sensi di un piano di trading Rule 10b5-1 adottato il 13 marzo 2025.

GRAIL, Inc. (GRAL) informó ventas de acciones por parte de un insider, el presidente Joshua Ofman, en un Formulario 4. El 15/10/2025 vendió 8,865 acciones comunes a un precio medio de 76,0276 USD. El 16/10/2025 vendió 6,114 acciones a un precio medio de 82,01 USD.

Tras estas transacciones, Ofman posee directamente 381,818 acciones. El documento señala que las ventas se realizaron conforme a un plan de negociación Rule 10b5-1 adoptado el 13 de marzo de 2025.

GRAIL, Inc. (GRAL)가 사장 Joshua Ofman에 의한 내부자 주식 매도를 Form 4에 보고했습니다. 2025년 10월 15일, 그는 보통주 8,865주를 평균가 76.0276달러에 매도했습니다. 2025년 10월 16일에는 6,114주를 평균가 82.01달러에 매도했습니다.

이 거래 후, Ofman은 직접 381,818주를 유익하게 보유합니다. 신고서에는 매도가 2025년 3월 13일에 채택된 Rule 10b5-1 거래 계획에 따라 이루어졌다고 명시되어 있습니다.

GRAIL, Inc. (GRAL) a signalé des ventes d’actions par un initié, le président Joshua Ofman, sur un formulaire 4. Le 15/10/2025, il a vendu 8 865 actions ordinaires à un prix moyen de 76,0276 dollars. Le 16/10/2025, il a vendu 6 114 actions à un prix moyen de 82,01 dollars.

Suite à ces transactions, Ofman détient directement 381 818 actions. Le dossier indique que les ventes ont été effectuées en vertu d’un plan de négociation Rule 10b5-1 adopté le 13 mars 2025.

GRAIL, Inc. (GRAL) meldete Insider-Verkäufe von Präsident Joshua Ofman in einem Formular 4. Am 15.10.2025 verkaufte er 8.865 Stammaktien zu einem durchschnittlichen Preis von 76,0276 USD. Am 16.10.2025 verkaufte er 6.114 Aktien zu einem durchschnittlichen Preis von 82,01 USD.

Nach diesen Transaktionen hält Ofman direkt 381.818 Aktien. Die Einreichung vermerkt, dass die Verkäufe gemäß einem am 13. März 2025 angenommenen Rule 10b5-1-Handelsplan erfolgt sind.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ofman Joshua J.

(Last) (First) (Middle)
C/O GRAIL, INC.
1525 O'BRIEN DRIVE

(Street)
MENLO PARK CA 94025

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GRAIL, Inc. [ GRAL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President
3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/15/2025 S 8,865 D(1) $76.0276 387,932 D
Common Stock 10/16/2025 S 6,114 D(1) $82.01 381,818 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025
Remarks:
/s/Donald Lang, as Attorney-in-Fact for Joshua Ofman 10/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did GRAIL (GRAL) disclose in this Form 4?

The filing reports that President Joshua Ofman sold common stock on 10/15/2025 and 10/16/2025 under a Rule 10b5-1 trading plan.

How many GRAL shares were sold and at what prices?

On 10/15/2025, 8,865 shares at $76.0276; on 10/16/2025, 6,114 shares at $82.01.

What is Joshua Ofman’s role at GRAIL (GRAL)?

He is an officer and serves as President.

How many GRAL shares does the insider own after these sales?

Following the transactions, he beneficially owns 381,818 shares directly.

Were these transactions under a 10b5-1 plan?

Yes. The sales were made pursuant to a Rule 10b5-1 plan adopted on March 13, 2025.

Were the reported holdings direct or indirect?

The holdings reported after the transactions are direct.
Grail Inc

NASDAQ:GRAL

GRAL Rankings

GRAL Latest News

GRAL Latest SEC Filings

GRAL Stock Data

2.72B
31.16M
13.81%
73.53%
13.42%
Diagnostics & Research
Services-medical Laboratories
Link
United States
MENLO PARK